Arsenic trioxide phosphorylates c-Fos to transactivate p21WAF1/CIP1 expression

Zi Miao Liu, Huei Sheng Huang

研究成果: Article

10 引文 斯高帕斯(Scopus)


An infamous poison, arsenic also has been used as a drug for nearly 2400 years; in recently years, arsenic has been effective in the treatment of acute promyelocytic leukemia. Increasing evidence suggests that opposite effects of arsenic trioxide (ATO) on tumors depend on its concentrations. For this reason, the mechanisms of action of the drug should be elucidated, and it should be used therapeutically only with extreme caution. Previously, we demonstrated the opposing effects of ERK1/2 and JNK on p21WAF1/CIP1 (p21) expression in response to ATO in A431 cells. In addition, JNK phosphorylates c-Jun (Ser63/73) to recruit TGIF/HDAC1 to suppress p21 gene expression. Presently, we demonstrated that a high concentration of ATO sustains ERK1/2 phosphorylation, and increases c-Fos biosynthesis and stability, which enhances p21 gene expression. Using site-directed mutagenesis, a DNA affinity precipitation assay, and functional assays, we demonstrated that phosphorylation of the C-terminus of c-Fos (Thr232, Thr325, Thr331, and Ser374) plays an important role in its binding to the p21 promoter, and in conjunction with N-terminus phosphorylation of c-Fos (Ser70) to transactivate p21 promoter expression. In conclusion, a high concentration of ATO can sustain ERK1/2 activation to enhance c-Fos expression, then dimerize with dephosphorylated c-Jun (Ser63/73) and recruit p300/CBP to the Sp1 sites (- 84/- 64) to activate p21 gene expression in A431 cells.

頁(從 - 到)297-307
期刊Toxicology and Applied Pharmacology
出版狀態Published - 2008 十二月 1

All Science Journal Classification (ASJC) codes

  • Toxicology
  • Pharmacology

指紋 深入研究「Arsenic trioxide phosphorylates c-Fos to transactivate p21<sup>WAF1/CIP1</sup> expression」主題。共同形成了獨特的指紋。

  • 引用此